Intrauterine Devices, Copper
Contraceptive Devices
Contraceptives, Oral
Intrauterine Device Migration
Contraceptives, Oral, Combined
Contraceptive Agents, Female
Uterine Perforation
Contraception
Pelvic Inflammatory Disease
Contraceptives, Oral, Hormonal
Contraceptives, Oral, Synthetic
Salpingitis
Uterine Hemorrhage
Family Planning Services
Plastics
Foreign-Body Migration
Actinomyces
Contraceptive Agents, Male
Desogestrel
Ethinyl Estradiol
Norgestrel
Levonorgestrel
Contraceptives, Postcoital
Uterus
Pregnancy
Mestranol
Norethindrone
Copper
Pregnancy, Unplanned
Sterilization, Reproductive
Device Approval
Medroxyprogesterone Acetate
Contraception, Postcoital
Spermatocidal Agents
Menstruation
Norethynodrel
Abortion, Induced
Ethynodiol Diacetate
Contraception, Immunologic
Norpregnenes
Ethinyl Estradiol-Norgestrel Combination
Progestins
Contraceptives, Oral, Sequential
Contraceptives, Postcoital, Hormonal
Sterilization, Tubal
Androstenes
Menstrual Cycle
Progesterone Congeners
Parity
Health Knowledge, Attitudes, Practice
Drug Implants
Equipment and Supplies
Megestrol
Contraceptives, Postcoital, Synthetic
Sex Education
Spermatogenesis-Blocking Agents
Ovulation Inhibition
Medroxyprogesterone
Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth. (1/72)
CONTEXT: Unintended pregnancy remains a major public health concern in the United States. Information on pregnancy rates among contraceptive users is needed to guide medical professionals' recommendations and individuals' choices of contraceptive methods. METHODS: Data were taken from the 1995 National Survey of Family Growth (NSFG) and the 1994-1995 Abortion Patient Survey (APS). Hazards models were used to estimate method-specific contraceptive failure rates during the first six months and during the first year of contraceptive use for all U.S. women. In addition, rates were corrected to take into account the underreporting of induced abortion in the NSFG. Corrected 12-month failure rates were also estimated for subgroups of women by age, union status, poverty level, race or ethnicity, and religion. RESULTS: When contraceptive methods are ranked by effectiveness over the first 12 months of use (corrected for abortion underreporting), the implant and injectables have the lowest failure rates (2-3%), followed by the pill (8%), the diaphragm and the cervical cap (12%), the male condom (14%), periodic abstinence (21%), withdrawal (24%) and spermicides (26%). In general, failure rates are highest among cohabiting and other unmarried women, among those with an annual family income below 200% of the federal poverty level, among black and Hispanic women, among adolescents and among women in their 20s. For example, adolescent women who are not married but are cohabiting experience a failure rate of about 31% in the first year of contraceptive use, while the 12-month failure rate among married women aged 30 and older is only 7%. Black women have a contraceptive failure rate of about 19%, and this rate does not vary by family income; in contrast, overall 12-month rates are lower among Hispanic women (15%) and white women (10%), but vary by income, with poorer women having substantially greater failure rates than more affluent women. CONCLUSIONS: Levels of contraceptive failure vary widely by method, as well as by personal and background characteristics. Income's strong influence on contraceptive failure suggests that access barriers and the general disadvantage associated with poverty seriously impede effective contraceptive practice in the United States. (+info)Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth. (2/72)
CONTEXT: Half of all pregnancies in the United States are unintended. Of these, half occur to women who were practicing contraception in the month they conceived, and others occur when couples stop use because they find their method difficult or inconvenient to use. METHODS: Data from the 1995 National Survey of Family Growth were used to compute life-table probabilities of contraceptive failure for reversible methods of contraception, discontinuation of use for a method-related reason and resumption of contraceptive use. RESULTS: Within one year of starting to use a reversible method of contraception, 9% of women experience a contraceptive failure--7% of those using the pill, 9% of those relying on the male condom and 19% of those practicing withdrawal. During a lifetime of use of reversible methods, the typical woman will experience 1.8 contraceptive failures. Overall, 31% of women discontinue use of a reversible contraceptive for a method-related reason within six months of starting use, and 44% do so within 12 months; however, 68% resume use of a method within one month and 76% do so within three months. Multivariate analyses show that the risk of contraceptive failure is elevated among low-income women and Hispanic women. Low-income women are also less likely than other women to resume contraceptive use after discontinuation. CONCLUSIONS: The risks of pregnancy during typical use of reversible methods of contraception are considerably higher than risks of failure during clinical trials, reflecting imperfect use of these methods rather than lack of inherent efficacy. High rates of method-related discontinuation probably reflect dissatisfaction with available methods. (+info)Obstetric and gynecology devices; effective date of requirement for premarket approval for glans sheath devices. Final rule. (3/72)
The Food and Drug Administration (FDA) is issuing a final rule to require the filing of a premarket approval application (PMA) or a notice of completion of product development protocol (PDP) for glans sheath medical devices. The agency has previously published its findings regarding the degree of risk of illness or injury designed to be eliminated or reduced by requiring the devices to meet the statute's approval requirements and the benefits to the public from the use of the devices. (+info)Contraceptive security, information flow, and local adaptations: family planning Morocco. (4/72)
BACKGROUND: Many developing countries increasingly recognize and acknowledge family planning as a critical part of socio-economic development. However, with few health dollars to go around, countries tend to provide essential drugs for curative care, rather than for family planning products. Donors have historically provided free contraceptives for family planning services. Whether products are donated or purchased by the country, a successful family planning program depends on an uninterrupted supply of products, beginning with the manufacturer and ending with the customer. Any break in the supply chain may cause a family planning program to fail. A well-functioning logistics system can manage the supply chain and ensure that the customers have the products they need, when they need them. METHODOLOGY: Morocco was selected for the case study. The researchers had ready access to key informants and information about the Logistics Management Information System. Because the study had time and resource constraints, research included desktop reviews and interview, rather than data collection in the field. RESULTS: The case study showed that even in a challenging environment an LMIS can be successfully deployed and fully supported by the users. It is critical to customize the system to a country-specific situation to ensure buy-in for the implementation. CONCLUSIONS: Significant external support funding and technical expertise are critical components to ensure the initial success of the system. Nonetheless, evidence from the case study shows that, after a system has been implemented, the benefits may not ensure its institutionalization. Other support, including local funding and technical expertise, is required. (+info)LEGAL IMPLICATIONS OF STERILIZATION. (5/72)
Sexual sterilization is legal when it is an integral part of a procedure for the preservation of the life or health of a patient. Done for other reasons it may not be illegal, but this has not been tested in Canadian courts. It is, broadly speaking, a surgical procedure; it is commonly, but not always, successful; complications, while rare, do occur; the results tend to be irreversible. The same end, the prevention of pregnancy, may be attained by other methods which are safer, less liable to complications, less permanent and so should be used unless contraindicated. Patients' statements that they do not like contraceptives should not be accepted as a reason for sterilization. Sexual sterilization should be reserved for those occasions when it is necessary for the preservation of the health or life of the individual who is to be sterilized. (+info)Gender issues in contraceptive use among educated women in Edo state, Nigeria. (6/72)
BACKGROUND: While traditional contraception is widely used, in southern Nigerian modern contraception is a relatively recent phenomenon. Modern contraception is more wide spread among the educated and sexually active youth in Nigeria. Few studies have been done on contraception among educated women in Nigeria. OBJECTIVES: This study was carried out in December 2000 to determine factors that influence the choice of contraceptives among female undergraduates at the University of Benin and Edo State University Ekpoma. METHODS: Data was collected from a sample of 800 female undergraduates matched ethnic group, socio economic status, religion and rural urban residence. Subjects were selected by proportional representation and the instrument used was closed ended questionnaire. RESULTS: The responses obtained were analysed using Spearman Rank Correlation co-efficient and regression analysis. Findings revealed the highest correlation for availability (r =.96) vis a vis the use of various types of artificial contraceptive and cost (r =.96), next was safety (r =.95) and effectiveness (r =.95). Others were peer group influence (r =.80) and convenience (r =.77). CONCLUSION: An important step in improving women's reproductive health is the involvement of men. Health programmes should conduct campaigns to educate men about reproductive health and the role they can assume in family planning. (+info)Contraceptive use and consistency in U.S. teenagers' most recent sexual relationships. (7/72)
CONTEXT: Most U.S. teenage pregnancies are unintended, partly because of inconsistent or no use of contraceptives. Understanding the factors associated with contraceptive use in teenagers' most recent relationships can help identify strategies to prevent unintended pregnancy. METHODS: Data on 1,468 participants in Waves 1 and 2 of the National Longitudinal Study of Adolescent Health who had had two or more sexual relationships were analyzed to assess factors associated with contraceptive use patterns in teenagers' most recent sexual relationship. Odds ratios were generated through logistic regression. RESULTS: Many relationship and partner characteristics were significant for females but nonsignificant for males. For example, females' odds of ever, rather than never, having used contraception in their most recent relationship increased with the duration of the relationship (odds ratio, 1.1); their odds were reduced if they had not known their partner before dating him (0.2). The odds of consistent use (vs. inconsistent or no use) were higher for females in a "liked" relationship than for those in a romantic relationship (2.6), and for females using a hormonal method instead of condoms (4.5). Females' odds of consistent use decreased if the relationship involved physical violence (0.5). Among teenagers in romantic or "liked" relationships, the odds of ever-use and of consistent use were elevated among females who had discussed contraception with the partner before their first sex together (2.9 and 2.1, respectively), and the odds increased among males as the number of presexual couple-like activities increased (1.2 for each). CONCLUSIONS: Teenagers must use contraception consistently over time and across relationships despite pressure not to. Therefore, they must learn to negotiate sexual and contraceptive decisions in each relationship. (+info)Women with septic abortion: who, how and why? A prospective study from tertiary care hospital in India. (8/72)
A prospective descriptive interview based hospital study was carried on 47 women admitted with septic abortion to evaluate their psychosocial, demographic and clinical profile These women were predominantly parous (75%), hindus (60%), between 20-30 years of age (60%) and mostly married (91.4%) house wives (63.8%). More than 90% already had one or more male child. The contraceptive use was dismally low (23.4%). Their knowledge about legalisation, place and persons authorized to conduct abortions was very less, however large majority (87%) underwent abortions within 3 months of pregnancy. Large family, poverty and spacing were the main reasons cited for abortions. Abdominal pain, fever, genital bleeding, diarhoea and abdominal distension were presenting clinical features in order of frequency. Advanced sepsis and associated medical and surgical complications were present in more than half the patients and 6% succumbed to these problems. The current experience was an eye opener for most of them and changed their future attitude. Hence education, economic prosperity, easy access to reproductive health facilities and institutional management of sepsis is the key to make abortions safe. (+info)The symptoms of intrauterine device migration can vary depending on the location and size of the migrated IUD. Some common symptoms include:
* Abnormal bleeding or spotting
* Painful menstrual cramps
* Difficulty inserting or removing the IUD during routine check-ups
* Fever, chills, or other signs of infection
If intrauterine device migration is suspected, a healthcare provider will typically perform a physical examination and order imaging tests, such as an ultrasound or X-ray, to confirm the location and size of the migrated IUD. Treatment options for intrauterine device migration depend on the severity of the complication and can include:
* Removal of the migrated IUD
* Insertion of a new IUD in a different location
* Antibiotics to treat any underlying infections
* Surgical intervention to repair any damage caused by the migrated IUD.
It is important for women who use intrauterine devices (IUDs) as a form of birth control to be aware of the risk of migration and seek medical attention if they experience any symptoms that may indicate a problem with their IUD. Regular check-ups with a healthcare provider can help detect any issues early on and prevent complications associated with intrauterine device migration.
There are different types of uterine perforation, including:
1. Cervical perforation: A tear in the cervix, which is the lower part of the uterus that opens into the vagina.
2. Uterine wall perforation: A tear or hole in the muscular wall of the uterus, which can be caused by instruments used during surgery or delivery.
3. Endometrial perforation: A tear in the lining of the uterus (endometrium), which is more common during invasive procedures such as hysteroscopy or endometrial ablation.
Symptoms of uterine perforation may include:
* Severe abdominal pain
* Heavy vaginal bleeding
* Fever
* Nausea and vomiting
If you suspect that you have a uterine perforation, it is essential to seek medical attention immediately. Your healthcare provider will perform a physical examination and order imaging tests such as ultrasound or CT scan to confirm the diagnosis and determine the extent of the damage. Treatment options may include:
1. Observation: In mild cases, the body may be able to heal on its own without any intervention.
2. Surgery: Depending on the severity of the perforation, surgical repair or removal of the damaged tissue may be necessary.
3. Antibiotics: If there is an infection, antibiotics will be prescribed to treat it.
4. Blood transfusions: In cases where there is significant bleeding, blood transfusions may be required.
Prevention of uterine perforation is crucial, and it involves proper training and use of instruments during surgery or delivery, as well as careful monitoring of the patient's condition during these procedures.
Symptoms of PID may include:
* Abdominal pain
* Fever
* Heavy vaginal discharge with a strong odor
* Pain during sex
* Painful urination
PID can be diagnosed through a combination of physical examination, medical history, and diagnostic tests such as pelvic exams, ultrasound, or blood tests. Treatment typically involves antibiotics to clear the infection, and may also involve hospitalization for severe cases. In some cases, surgery may be necessary to repair any damage caused by the infection.
Preventive measures for PID include:
* Safe sexual practices, such as using condoms and avoiding sexual intercourse during outbreaks of STIs
* Regular gynecological exams and screening for STIs
* Avoiding the use of douches or other products that can disrupt the natural balance of bacteria in the vagina.
Symptoms of salpingitis may include:
* Pain in the lower abdomen
* Fever
* Abnormal vaginal bleeding or spotting
* Abdominal tenderness
* Nausea and vomiting
Diagnosis of salpingitis is typically made through a combination of physical examination, medical history, and diagnostic tests such as pelvic ultrasound, endometrial biopsy, and laparoscopy. Treatment usually involves antibiotics to clear up any underlying infections, as well as pain management and other supportive measures. In some cases, surgery may be necessary to remove the affected fallopian tube or tubes.
Salpingitis can have serious complications if left untreated, such as chronic pelvic pain, infertility, and ectopic pregnancy (when an embryo implants outside of the uterus). Therefore, it is important for women who experience any symptoms of salpingitis to seek medical attention promptly.
Symptoms of a uterine hemorrhage may include:
* Vaginal bleeding that may be heavy or light in flow
* Pain in the lower abdomen
* Pain during sexual activity
* Spotting or bleeding between menstrual periods
* Unusual discharge from the vagina
If you experience any of these symptoms, it is important to seek medical attention as soon as possible. Uterine hemorrhages can be diagnosed through a physical examination and imaging tests such as ultrasound or MRI. Treatment depends on the underlying cause of the bleeding, but may include medications to control bleeding, surgery to remove fibroids or polyps, or hysterectomy in severe cases.
It is important to note that while uterine hemorrhages can be managed with appropriate medical care, they can also be life-threatening if left untreated. Seeking prompt medical attention and following the advice of your healthcare provider are crucial to preventing complications and ensuring a successful outcome.
Actinomycosis is often difficult to diagnose because the symptoms are non-specific and can mimic other conditions, such as cancer or tuberculosis. A definitive diagnosis requires a combination of clinical findings, radiologic imaging, and microbiological cultures. Treatment usually involves long-term antibiotics, surgical drainage of abscesses, and management of complications.
Actinomycosis can affect people of all ages, but it is more common in adults and rarely seen in children. The infection can be acquired through direct inoculation of the bacteria into the skin or mucous membranes, or through hematogenous spread from a primary site of infection.
The risk factors for developing actinomycosis include poor oral hygiene, dental procedures, surgical trauma, and exposure to contaminated soil or water. The infection can also be associated with underlying conditions such as immunosuppression, diabetes, and chronic lung disease.
In conclusion, actinomycosis is a rare and chronic bacterial infection that can affect various parts of the body, causing inflammation and formation of abscesses. It can be difficult to diagnose and treat, and requires a comprehensive approach involving antibiotics, surgery, and management of complications.
Causes of Menorrhagia
-------------------
There are several potential causes of menorrhagia, including:
1. Hormonal imbalance: Hormonal changes can lead to an imbalance in the uterus, causing excessive bleeding.
2. Uterine fibroids: These noncancerous growths in the uterus can cause heavy bleeding during menstruation.
3. Adenomyosis: This condition occurs when tissue similar to the lining of the uterus grows into the muscle of the uterus, leading to heavy bleeding.
4. Endometrial polyps: These are growths that can develop on the lining of the uterus and cause heavy bleeding.
5. Thyroid disorders: Both hypothyroidism (underactive thyroid) and hyperthyroidism (overactive thyroid) can cause menorrhagia.
6. Pelvic inflammatory disease (PID): This is an infection of the reproductive organs that can cause scarring and lead to heavy bleeding.
7. IUDs: Intrauterine devices (IUDs) can cause heavy bleeding, especially during the first few months after insertion.
8. Medications: Certain medications such as anticoagulants and anti-inflammatory drugs can increase the risk of menorrhagia.
9. Bleeding disorders: Women with bleeding disorders, such as von Willebrand disease or platelet dysfunction, may experience heavy menstrual bleeding.
10. Cancer: In rare cases, menorrhagia can be a symptom of uterine cancer.
Symptoms of Menorrhagia
-------------------------
The primary symptom of menorrhagia is heavy menstrual bleeding that lasts for more than 7 days or bleeds that are heavier than usual. Other symptoms may include:
1. Soaking through sanitary products every hour or two
2. Using double sanitary products (e.g., a pad and a tampon) to control bleeding
3. Bleeding that lasts for more than 7 days
4. Menstrual blood clots larger than a quarter
5. Painful menstruation (dysmenorrhea)
6. Passing large blood clots during bowel movements or urination
7. Fatigue, dizziness, or fainting due to anemia
8. Weakness or shortness of breath
Diagnosis and Treatment of Menorrhagia
-------------------------------------
If you experience any of the symptoms of menorrhagia, it is important to see a healthcare provider for proper diagnosis and treatment. The healthcare provider will perform a physical examination and may order one or more of the following tests to determine the cause of heavy menstrual bleeding:
1. Complete Blood Count (CBC) to check for anemia and other blood abnormalities
2. Blood smear examination to look for abnormal cells or blood clotting disorders
3. Ultrasound to evaluate the uterus and ovaries
4. Endometrial biopsy to examine the lining of the uterus
5. Hysteroscopy to visualize the inside of the uterus
6. Laparoscopy to evaluate the pelvic organs
Treatment for menorrhagia depends on the underlying cause and may include:
1. Medications such as hormonal contraceptives, nonsteroidal anti-inflammatory drugs (NSAIDs), or iron supplements to control bleeding and anemia
2. Surgical procedures such as endometrial ablation or hysterectomy in severe cases that do not respond to other treatments
3. Lifestyle changes such as avoiding caffeine, alcohol, and spicy foods, as well as taking regular exercise and maintaining a healthy diet
4. Hormone replacement therapy (HRT) to regulate hormonal imbalances
5. Platelet transfusions or blood transfusions in cases of severe bleeding
It's important to note that menorrhagia can be a symptom of a more serious underlying condition, so it's essential to seek medical attention if you experience any of the following:
1. Prolonged or heavy menstrual bleeding (more than 7 days)
2. Bleeding between periods or after sex
3. Painful periods or difficulty using tampons
4. Fever, chills, or vomiting during menstruation
5. Unusual vaginal discharge or odor
6. Abdominal pain or bloating
Early diagnosis and treatment can help manage symptoms and prevent complications of menorrhagia, such as anemia, fatigue, and infertility.
Foreign-body migration refers to the movement or migration of a foreign object or material within the body over time. This can occur after a surgical procedure, injury, or other medical intervention where a foreign object is introduced into the body. The term "foreign body" includes any object or material that is not naturally present within the body, such as implants, sutures, staples, and other medical devices.
The migration of a foreign body can occur due to various factors, including:
1. Mechanical forces: Movement of the body, such as during exercise or daily activities, can cause the foreign object to shift position or migrate to another part of the body.
2. Biological forces: The body's natural healing processes and inflammatory responses can cause the foreign object to move or change shape over time.
3. Chemical forces: Corrosion or degradation of the foreign material can lead to its migration within the body.
4. Cellular forces: Cells in the body can surround and interact with the foreign object, leading to its movement or displacement.
The migration of a foreign body can have significant clinical implications, including:
1. Pain and discomfort: The movement of a foreign object within the body can cause pain, discomfort, and inflammation.
2. Infection: The migration of a foreign object can increase the risk of infection, particularly if the object is made of a material that is susceptible to bacterial growth.
3. Organ damage: If the migrated foreign object damages surrounding tissues or organs, it can lead to serious complications and long-term health problems.
4. Revision surgery: In some cases, the migration of a foreign body may require revision surgery to remove or reposition the object.
To prevent foreign-body migration, medical professionals use various techniques, such as:
1. Implant fixation: Implants can be fixed in place using bone screws, sutures, or other fixation devices to minimize their movement.
2. Biocompatible materials: Using biocompatible materials for implants and other medical devices can reduce the risk of foreign-body reaction and migration.
3. Proper surgical technique: Surgeons must use proper surgical techniques when inserting foreign objects into the body, such as using a sterile environment and appropriate insertion angles.
4. Postoperative care: Proper postoperative care, including antibiotics and pain management, can help prevent complications and promote healing.
Overall, preventing the migration of foreign bodies is essential to ensure successful medical outcomes and minimize the risk of complications.
Also known as: Menstrual Disorders, Menstrual Abnormalities, Dysmenorrhea, Amenorrhea, Oligomenorrhea, Polymenorrhea.
Hormonal intrauterine device
Intrauterine device
Combined oral contraceptive pill
Birth control in France
Birth control
Levonorgestrel
GroES
Edward Truelove
Siva Chinnatamby
Beginning of pregnancy controversy
Anaerobic infection
Contraceptive vaginal ring
Long-acting reversible contraceptives
Condom (disambiguation)
Vaginal ring
Contraceptive patch
Essure
Copper IUD
Carl Djerassi
Brave New World
Contraceptive mandate
Lionel Emmett
Contraception in the Republic of Ireland
PATH (global health organization)
Monika Krause-Fuchs
Lazar C. Margulies
Combined injectable birth control
Combined hormonal contraception
Medroxyprogesterone acetate
Second-wave feminism
Jewish views on contraception
Cervical cancer
Childbirth
Reproductive coercion
List of landmark court decisions in the United States
History of human sexuality
Becket Law
Fatal Misconception
Pharmaceutical industry
Irreligion in Mexico
Charlie Baker
List of Ig Nobel Prize winners
List of The Hitchhiker's Guide to the Galaxy characters
Microbicides for sexually transmitted diseases
Ruta graveolens
Women in Turkey
Femtech
Endometrial cancer
IUS
Abortion in India
Open relationship
Diana Zuckerman
Conception device
Matthew H. Liang
Tubal ligation
Childbirth in Mexico
Abortion
John Aitken (biologist)
Summary of Classifications for Hormonal Contraceptive Methods and Intrauterine Devices | CDC
Browsing by Subject "Contraceptive Devices"
Ocon IUB Intra Uterine Ball Contraceptive Device Going to Clinical Trials (video)
Incidence of Sexually Transmitted Infections Before and After Insertion of an Intrauterine Device or Contraceptive Implant,...
Contraceptive Devices: An Overview - CondomMan.com
Coagulation factors in women using oral contraceptives or intrauterine contraceptive devices immediately after abortion - PubMed
UK court order requiring contraceptive device for disabled woman is 'deeply problematic', says bioethicist - Catholic World...
Effect of an intrauterine contraceptive device on uterine motility in the rat. | Scholars@Duke
Birth control: Types, devices, injections, and permanent birth control
Subjects: Contraceptive Devices, Female -- statistics & numerical data - Digital Collections - National Library of Medicine...
Microsoft word - intrauterine contraceptive devices.docx
Insertion of intrauterine contraceptive device | Practice Plus Group
Results of search for 'su:{Contraceptive devices}'
›
WHO HQ Library catalog
Birth Control | Contraception | Contraceptives | MedlinePlus
Immediate postpartum intrauterine contraceptive device utilization and associated factors among women who gave birth in public...
Effect of age on pelvic inflammatory disease in nulliparous women using a copper 7 intrauterine contraceptive device. -...
DailyMed - Search Results for Progestin-containing Intrauterine Device
Birth Control | Contraception | Contraceptives | MedlinePlus
Contraceptive Care Toolkit | Health.mil
Ectopic Pregnancy: Practice Essentials, Background, Etiology
Essure Contraceptive Device The Target Of Legislation For FDA Ban - The Olinde Firm - New Orleans Attorneys
Heart disease and contraception/pregnancy | Royal Brompton & Harefield hospitals
Contraceptives - LC Linked Data Service: Authorities and Vocabularies | Library of Congress
510(k) Premarket Notification
RFA-HD-19-015: Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed)
A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine...
Women's Sexual Health | Medscape
Table 1 - Cost-effectiveness of Increasing Access to Contraception during the Zika Virus Outbreak, Puerto Rico, 2016 - Volume...
Intrauterine contraceptive devices1
- The evidence on utilization of immediate postpartum intrauterine contraceptive devices (IPPIUCDs) and its associated factors are limited in Ethiopia . (bvsalud.org)
Hormonal8
- Health-care providers can use the summary table as a quick reference guide to the classifications for hormonal contraceptive methods and intrauterine contraception to compare classifications across these methods ( Box K1 ) ( Table K1 ). (cdc.gov)
- Hormonal contraceptives and intrauterine devices do not protect against sexually transmitted diseases (STDs), including human immunodeficiency virus (HIV), and women using these methods should be counseled that consistent and correct use of the male latex condom reduces the risk for transmission of HIV and other STDs. (cdc.gov)
- Long-acting reversible contraceptive (LARC) use, including subdermal hormonal implants and intrauterine devices (IUDs), has been increasing for almost 2 decades, from 1.5-2.5% of U.S. women of childbearing age in the early 2000s 1,2 to 10.3-14.3% between 2009 and 2015. (health.mil)
- Six mothers had a levonorgestrel-releasing IUD and seven others the Nova-T or no hormonal or intrauterine contraceptive. (nih.gov)
- Emergency contraceptive pills (ECPs), which are hormonal pills which the woman takes as soon as possible after unprotected intercourse. (nih.gov)
- It is important to know that pregnancy also increases the risk for blood clots, and much more significantly than any hormonal contraceptive. (mountsinai.org)
- Inhibition of sperm motility in male macaques with EP055, a potential non-hormonal male contraceptive. (nih.gov)
- 5. Intrauterine devices: an effective alternative to oral hormonal contraception. (nih.gov)
IUDs2
- Phase 1: Copayments and cost-shares for long-acting reversible contraceptives services such as placing and removal of IUDs, contraceptive shots, and subdermal contraceptive rods will be waived beginning Nov. 1, 2022. (health.mil)
- The American Academy of Pediatrics and the American College of Obstetricians and Gynecologists (ACOG) recommend intrauterine devices (IUDs) and contraceptive implants (Nexplanon) as first-line contraceptive options for sexually active teens based on the effectiveness of these contraceptives and high rates of patient satisfaction. (mountsinai.org)
Condoms4
- The downside of this birth control device is the need to use fresh condoms for every sexual act. (condomman.com)
- Though these inserted contraceptives do afford women control over their sexual lives, it is still best to ask your partners to do their part and use some forms of contraceptives themselves, like the use of condoms. (condomman.com)
- A study compared prolactin serum concentrations in 40 women using a copper-containing intrauterine device (Copper T, Copper 7 or Soonawalla Y) to those of 20 women who were using condoms or practicing abstinence. (nih.gov)
- Most-such as birth control pills, vaginal rings, female condoms, and intrauterine devices-rely on the woman. (nih.gov)
Implant4
- Between 1 Jan. 2015 and 31 Dec. 2018, 18,691 service women in the study population received an intrauterine device (IUD) and 17,723 received an implant. (health.mil)
- In general, among service women who began using LARC (an IUD or a contraceptive implant), incidence rates of STIs did not increase from the year before to the year after insertion. (health.mil)
- Just like a contraceptive implant, IUD is reversible. (feministpeacenetwork.org)
- 16. Enlarged ovarian follicles in users of a levonorgestrel-releasing intrauterine system and contraceptive implant. (nih.gov)
Contraception5
- To increase contraceptive choices, TRICARE is waiving copayments and cost-shares on medical contraception such as long-acting reversible contraceptives (LARCs) and permanent contraception. (health.mil)
- For some patients, an intrauterine device may be a good choice for emergency contraception. (mountsinai.org)
- In addition to contraception, the devices in the study, titled, Medical Device Approvals Through the Premarket Approval Pathway in Obstetrics and Gynecology From 2000 to 2015: Process and Problems, were approved for things such as reducing menstrual flow and fetal monitoring. (lifesitenews.com)
- 11. Acceptability of randomization to levonorgestrel versus copper intrauterine device among women requesting IUD insertion for contraception. (nih.gov)
- 13. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception. (nih.gov)
Methods7
- As well as being able to tell you how your condition can affect the contraceptive you take, they can advise you what methods are most suited to you. (rbht.nhs.uk)
- The suitability of different contraceptive methods may depend on other illnesses that you have, the medicines that you are taking, and your own personal preference. (rbht.nhs.uk)
- Two birth control methods, the contraceptive sponge and the diaphragm , have been linked to TSS. (kidshealth.org)
- This FOA supports the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in its mission to develop novel, safe and effective contraceptive methods for men and women. (nih.gov)
- The PCDP is a research program formed to expand research leading to the development of male and female contraceptive methods. (nih.gov)
- Contraceptives are devices, drugs, or methods for preventing pregnancy either by preventing the fertilization of the female egg by the male sperm or by preventing implantation of the fertilized egg. (mountsinai.org)
- 7. Use of contraceptive methods among women with endometrial hyperplasia: a systematic review. (nih.gov)
Long-term contraceptive2
Nonsteroidal contraceptive1
- The purpose of this funding opportunity announcement (FOA) is to support and facilitate multidisciplinary research approaches for the development of novel nonsteroidal contraceptive products for men and women that act prior to fertilization. (nih.gov)
Insertion4
- At Practice Plus Group we offer fast access to high-quality insertion of intrauterine contraceptive device procedure via self-pay, insured and NHS routes. (practiceplusgroup.com)
- In women who are breastfeeding, insertion of the device should be after 4 weeks postpartum. (nih.gov)
- 1 ] A more recent prospective study found a slight increase in the risk of expulsion of intrauterine devices with breastfeeding,[ 2 ] and the American College of Obstetrics and Gynecology recommends that women be counseled that immediate postpartum insertion may have a higher expulsion rate than later insertion. (nih.gov)
- Milk samples were collected at 10 weeks postpartum before insertion and 6 weeks after insertion of the devices from 21 women in the first study group, 22 in the second study group and 20 women in the control group. (nih.gov)
Sponge2
- Another barrier birth control device is the sponge, made of polyurethane and is placed on the cervix before the sex act. (condomman.com)
- A contraceptive sponge is inserted into the vagina. (medicalnewstoday.com)
Reversible contraceptives1
- Effective July 28, 2022, copayment and cost-shares were waived for long-acting reversible contraceptives. (health.mil)
Levonorgestrel4
- Women of all ages can now get the levonorgestrel emergency contraceptive pill Plan B One-Step and its generic versions without a prescription. (mountsinai.org)
- 14. Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer. (nih.gov)
- 18. Levonorgestrel intrauterine device (IUD) exacerbation of PMS symptoms. (nih.gov)
- 19. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study. (nih.gov)
Sperm2
- It is an effective birth control device in such as way that it blocks the sperm from getting into the womb. (condomman.com)
- Barrier devices prevent the sperm from meeting the egg. (medicalnewstoday.com)
Diaphragm2
- A diaphragm is a device similar to the cervical cap, though made of flexible rubber. (condomman.com)
- As with the diaphragm and the cervical cap, this birth control device has the risk of toxic shock syndrome when not removed after several hours. (condomman.com)
Vaginal1
- N = 734) intrauterine device were compared to women who received a vaginal ring that released about 10 mg daily of progesterone (N = 802) beginning at day 29 to 63 postpartum. (nih.gov)
Emergency2
- Emergency contraceptives (e.g. (health.mil)
- 3 ] The copper IUD is considered to be the most effective emergency contraceptive when inserted up to 5 days after unprotected intercourse. (nih.gov)
Essure11
- The Essure Contraceptive Device is a medical device touted as the only nonsurgical sterilization device. (olindefirm.com)
- Over 5,000 formal complaints have been filed with the FDA regarding women who experienced harmful complications from the Essure device. (olindefirm.com)
- There have been nine total deaths related to the device, four adults and five unborn fetus', all of which involved a pregnancy that the Essure device was intended to prevent. (olindefirm.com)
- Congressman Mike Fitzpatrick (R-PA) is introducing a bill to ban the Essure device from the market. (olindefirm.com)
- He cites over 22,000 women who have come forward on Facebook alone to report harmful complications and side effects resulting from the Essure Sterilization device. (olindefirm.com)
- Such is the case with the Essure device, as many of the women who suffer serious injury with the implanted device end up requiring a complete hysterectomy to reverse the injuries suffered. (olindefirm.com)
- Our law firm believes you should be compensated for injuries sustained by a dangerous or defective medical product , like the Essure contraceptive device. (olindefirm.com)
- If you have been implanted with an Essure device, you may be eligible for compensation for any injuries or complications sustained as a result of that device. (olindefirm.com)
- June 6, 2016 ( LifeSiteNews ) - The U.S. Food and Drug Administration has used faulty data to approve many high-risk ob-gyn medical devices in the last 15 years, a new study says, including the controversial contraceptive device Essure. (lifesitenews.com)
- Recent controversies surrounding obstetrics and gynecology devices" including among other things, the Essure contraceptive coil device, "highlight the need for deeper understanding of obstetrics and gynecology medical device regulation," the study's authors, based at Northwestern University, said . (lifesitenews.com)
- The authors identified Essure, classified as a "permanent contraceptive device" intended to last a lifetime, as among 18 devices posing the greatest risk to patients that were green-lighted by the FDA between 2000 and 2015. (lifesitenews.com)
Injection1
- According to the BBC, the woman agreed to having a contraceptive injection every three months, but did not want to be fitted with a contraceptive device. (catholicworldreport.com)
Oral2
- If you are extra cautious, taking an oral contraceptive pill daily should be included in your routine. (feministpeacenetwork.org)
- An open-label, two-center, randomized study in breastfeeding women compared a copper-containing IUD (Multiload Cu250) with an oral progestin-only contraceptive (lynestrenol 500 mcg). (nih.gov)
Uterine5
- Israel's Globes newspaper is reporting that Ocon Medical is about to begin clinical trials of company's IUB (Intra Uterine Ball) contraceptive device that was designed to solve a few of the possible implantation downsides of current offerings, such as malpositioning, perforations, and expulsions. (medgadget.com)
- When deployed into the uterine cavity, the IUBâ„¢ turns away from the fundus, maintains a diameter larger than the cervical canal and has superior flexibility and minimal tissue protrusion compared to current devices. (medgadget.com)
- Effect of an intrauterine contraceptive device on uterine motility in the rat. (duke.edu)
- 2. Intrauterine device use among women with uterine fibroids: a systematic review. (nih.gov)
- 15. Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study. (nih.gov)
Drugs4
- Birth control is the use of various devices, drugs, agents, sexual practices, or surgical procedures to prevent conception or pregnancy. (medicalnewstoday.com)
- The study's are asking why the FDA has lowered standards for high-risk medical devices than many drugs. (lifesitenews.com)
- Xu further questioned the fact that medical devices have lower approval criteria than drugs. (lifesitenews.com)
- The important question to ask is: should we really be holding high-risk medical devices to a lower standard of evidence than drugs? (lifesitenews.com)
Pregnancy2
- A range of devices and treatments are available for both men and women that can help prevent pregnancy. (medicalnewstoday.com)
- Access to comprehensive contraceptive counseling is critical to address the timing and choice regarding family planning and prevention of pregnancy. (health.mil)
Women7
- Some women also report of getting urinary tract infection because of this device. (condomman.com)
- Effect of age on pelvic inflammatory disease in nulliparous women using a copper 7 intrauterine contraceptive device. (ox.ac.uk)
- Immediate postpartum intrauterine contraceptive device utilization and associated factors among women who gave birth in public health facilities of Adama town, Ethiopia. (bvsalud.org)
- Devices are a huge part of the medical care that we provide women on a daily basis," the study's lead author Doctor Jessica Walter said. (lifesitenews.com)
- 1. Intrauterine device use among women with ovarian cancer: a systematic review. (nih.gov)
- 8. Use of intrauterine devices in nulliparous women. (nih.gov)
- 10. [Reasons for removal of intrauterine devices among women in general practice]. (nih.gov)
Intercourse1
- Copper IUD, which is a small, T-shaped device that a provider inserts into the within 120 hours of unprotected intercourse. (nih.gov)
Barrier2
- For the sake of discussion, some contraceptives are classified under the barrier birth control method. (condomman.com)
- However, it might take a little while to get used to and some men might get turned off by this barrier birth control device. (condomman.com)
Obstetrics and Gyneco2
- Our results reveal significant weaknesses in the preapproval and post approval regulation of high-risk obstetrics and gynecology devices. (lifesitenews.com)
- The Northwestern University study's authors say that their results, published in the June 2016 journal Obstetrics and Gynecology , show that the FDA approvals should be based upon more rigorous clinical studies than required now, both before and after the devices make it onto the market. (lifesitenews.com)
Effective1
- Our concern is that this would lead to more devices getting approved with even less clinical evidence that they are both safe and effective. (lifesitenews.com)
Copper2
- This t-shape device is typically made of plastic and copper. (feministpeacenetwork.org)
- Two groups used copper-containing intrauterine devices (Copper 380A [n = 33] and Copper 200B [n = 29]), and a third group that did not use any IUD (n = 33) served as control. (nih.gov)
Effectiveness2
- Four of the devices, or 22 percent, were approved despite failing to demonstrate effectiveness in clinical trials. (lifesitenews.com)
- Unfortunately, this most recent study is not unique: many studies have shown that the FDA frequently approves even the highest-risk medical devices without adequate evidence of safety and effectiveness," said Sarah Sorscher, researcher with Public Citizen , a watchdog organization founded by consumer advocate Ralph Nader. (lifesitenews.com)
Acceptability1
- The Family Planning Association approved list of contraceptives : based on available data on efficacy and acceptability. (who.int)
Birth control3
- These inserted devices also need to be reapplied before each and every sexual act in order to achieve efficacy in birth control. (condomman.com)
- Insist on the use of birth control devices as a sign of maturity and deference to the overall health of both partners. (condomman.com)
- Traditional birth control does not involve any type of device or medication. (medicalnewstoday.com)
Efficacy1
- Depending on which type of IUD you choose, the device can last between three and ten years, with an efficacy rate of up to 99.8 percent. (feministpeacenetwork.org)
Method2
Surgery1
- Ironically, surgery is often required to correct the damage done by a medical device intended to avoid surgery. (olindefirm.com)
Permanent1
- Sometimes, even that is not enough, sometimes, the injuries sustained from this defective medical device are permanent. (olindefirm.com)
Regulation2
- 3) Except as authorized by regulation, no person shall advertise to the general public any contraceptive device or any drug manufactured, sold or represented for use in the prevention of conception. (gc.ca)
- Authors of the study also expressed concern over the "21st Century Cures Act," legislation passed last year in the U.S. House of Representatives containing provisions to reduce medical device regulation that is now under consideration in the Senate. (lifesitenews.com)
Female1
- The program addresses development of both male and female contraceptives. (nih.gov)
Services1
- Is there a copayment waiver for contraceptive services? (health.mil)
Options1
- This comprehensive communication campaign focuses on raising awareness of contraceptive options as well as drawing attention to recent copayment waivers. (health.mil)
Option1
- Researchers have been trying to develop another contraceptive option for men. (nih.gov)
Medical Device1
- As a Louisiana injury law firm that handles defective medical device claims and pharmaceutical litigation , we meet far too many people who were injured by a medical device that was marketed deceptively - you deserve to know the risks involved before you agree to a device. (olindefirm.com)
Risk1
- In addition to supporting contraceptive development research on validated modulations, this FOA supports early stage, high-risk projects lacking validation by allowing validation during the R61 phase. (nih.gov)
Hours1
- This device must not remain in the body for more than 48 hours, to avoid toxic shock syndrome, and would need to be replaced yearly. (condomman.com)
Increase1
- We found that there's an opportunity to increase the burden of proof required for a device to be approved for public use. (lifesitenews.com)
Postpartum1
- Strategies to raise pregnant mothers ' awareness of IPPIUCD through mass media , and integrating standard counseling on immediate postpartum intrauterine device (IPPIUD) during antenatal care , and the immediate postpartum period are required to improve IPPIUD utilization. (bvsalud.org)